Ebola is on the run: the number of cases dipped below 10 a week recently, and a few days ago investigators announced in the prestigious journal The Lancet that a new Ebola vaccine was “100 ...

One possible way to curb the infections is the use of a vaccine that would inoculate those at risk. In September an Ebola vaccine developed by the U.S. National Institute for Health will be tested ...

GlaxoSmithKline makes Ebola vaccine stockpiles as human trials begin. — -- The first human trial for an investigational Ebola vaccine is set to begin this week. The ongoing Ebola outbreak in ...

It confirms just how major an advancement the Ebola vaccine remains; the study is the first to show that in addition to preventing infections, the vaccine can save some people who are already sick ...

The first human trials of a Canadian Ebola vaccine began Monday, part of a flood of experimental therapies rushed into testing to battle the Ebola epidemic. Although the world has been fighting ...

It’s official. We now have a real Ebola vaccine. Not a kind-of-almost-sort-of-there vaccine. Not an experimental-use vaccine. Not a vaccine just for macaques. No, this is a vaccine that the ...

There were no drugs or vaccines approved to treat or prevent Ebola or ready to enter into clinical trials at the outset of the epidemic. Therefore, many felt it was ethically necessary to conduct ...

Outbreaks of the deadly Ebola virus flare up in parts of Africa almost every year. The virus kills about half the people it infects. But a new study shows that a vaccine already in use is offering ...

Over time, however, researchers have developed ways to fight back against Ebola, including rVSVΔG-ZEBOV-GP, a single-dose intramuscular vaccine that causes cells to make one of the virus's proteins.

The popular instinct about the potential of vaccines to address the horrific Ebola outbreak in West Africa is: Why delay? If there’s any chance they’ll work, let’s get them out now.